Colorectal Cancer Metastatic Clinical Trials
0 recruiting
Showing 1–20 of 22 trials
Recruiting
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
Colorectal Cancer MetastaticLiver Transplant SurgeryColon Cancer Liver Metastases
Northwestern University80 enrolled1 locationNCT06698146
Recruiting
Phase 2
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
Colorectal Cancer MetastaticIntrahepatic Cholangiocarcinoma
Michael J Cavnar, MD80 enrolled1 locationNCT07201519
Recruiting
Phase 1Phase 2
A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
Colorectal Cancer Metastatic
Carina Biotech Limited45 enrolled1 locationNCT05759728
Recruiting
Phase 2
STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
Colorectal Cancer Metastatic
National Cancer Institute, Naples60 enrolled1 locationNCT07213570
Recruiting
Phase 2
A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.
Triple Negative Breast Cancer MetastaticMelanoma MetastaticColorectal Cancer Metastatic
Fudan University95 enrolled1 locationNCT06889610
Recruiting
Phase 3
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Colorectal Cancer Metastatic
Shanghai Kechow Pharma, Inc.165 enrolled1 locationNCT06008119
Recruiting
Phase 2
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
ChemotherapyTargeted TherapyImmunotherapy+2 more
Sun Yat-sen University57 enrolled1 locationNCT06764680
Recruiting
Early Phase 1
A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer
Colorectal Cancer MetastaticColorectal Cancer RecurrentColorectal Cancer Stage IV
Shanghai Changzheng Hospital20 enrolled1 locationNCT07050394
Recruiting
Phase 2
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
Colorectal Cancer Metastatic
Chinese PLA General Hospital30 enrolled1 locationNCT07044921
Recruiting
Phase 1
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
Colorectal Cancer MetastaticLung Metastases
University Health Network, Toronto10 enrolled1 locationNCT05611034
Recruiting
Phase 2
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
Colorectal Cancer Metastatic
Sun Yat-sen University194 enrolled1 locationNCT05727163
Recruiting
Phase 2
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
Liver MetastasesColorectal Cancer Metastatic
Weill Medical College of Cornell University24 enrolled1 locationNCT06300463
Recruiting
Phase 2
Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
Colorectal Cancer Metastatic
Fudan University36 enrolled1 locationNCT06763029
Recruiting
Phase 2
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
Colorectal Cancer Metastatic
The Fourth Affiliated Hospital of Zhejiang University School of Medicine36 enrolled1 locationNCT06282445
Recruiting
Not Applicable
Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC
Colorectal Cancer Metastatic
The First People's Hospital of Changzhou30 enrolled1 locationNCT06456515
Recruiting
Phase 1Phase 2
XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.
Biliary Tract CancerOvarian CancerGastric Carcinoma+4 more
Evopoint Biosciences Inc.240 enrolled1 locationNCT06792435
Recruiting
Phase 2
Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer
Colorectal Cancer MetastaticMicrosatellite Stable Colorectal CarcinomaRefractory Mismatch-repair-proficient (pMMR) Metastatic Colorectal Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS36 enrolled2 locationsNCT06522919
Recruiting
Not Applicable
PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
Colorectal Cancer Metastatic
National Cancer Institute, Naples25 enrolled1 locationNCT04854213
Recruiting
Phase 2
Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
Colorectal Cancer Metastatic
Sun Yat-sen University34 enrolled1 locationNCT06547203
Recruiting
Not Applicable
Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver Metastases
Liver MetastasesColorectal Cancer Metastatic
Jena University Hospital40 enrolled2 locationsNCT03488953